Coronavirus: the Commission signs second contract to ensure access to a potential vaccine
A second contract with a pharmaceutical company recently (18 September 2020) came into force following the contract's formal signature between Sanofi-GSK and the Commission. The contract will allow all EU Member States to purchase up to 300 million doses of the Sanofi-GSK vaccine. Moreover, Member States may donate reserved doses to lower- and middle-income countries. Sanofi and GSK will also endeavour to provide a significant portion of their vaccine supply through a collaboration with the COVID-19 Vaccines Global Access (COVAX) facility - the vaccine pillar of the Access to COVID-19 Tools Accelerator for lower and middle income countries - in a timely manner.
The Commission has already signed a contract with AstraZeneca and continues discussing similar agreements with other vaccine manufacturers (Johnson & Johnson, CureVac, Moderna and BioNTech) with which it has concluded exploratory talks.
President von der Leyen recently said:
“With today's contract with Sanofi-GSK, the European Commission shows once again its commitment to ensuring equitable access to safe, effective and affordable vaccines not only for its citizens but also for the world's poorest and most vulnerable people. Agreements with other companies will be concluded soon and build a diversified portfolio of promising vaccines, based on various types of technologies, increasing our chances to find an effective remedy against the virus.”
Stella Kyriakides, Commissioner for Health and Food Safety, recently said:
“With several countries in Europe experiencing new outbreaks after the summer period, a safe and effective vaccine is more instrumental than ever to overcome this pandemic and its devastating effects on our economies and societies. This second agreement is yet another milestone in our EU Vaccine Strategy. Today we are expanding our possibilities to ensure that EU citizens and citizens around the world can gradually resume daily life and feel safe again.”
The recent contract is financed by the Emergency Support Instrument, which dedicates funds to the creation of a portfolio of potential vaccines with different profiles and produced by different companies.
Sanofi and GSK are developing a recombinant vaccine for COVID-19, using innovative technology from both companies. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. GSK will contribute its adjuvant technology, of particular importance in a pandemic situation since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced and therefore helping to protect more people. The combination of a protein-based antigen together with an adjuvant is well-established and used in a number of vaccines available today to enhance the immune response. It can also improve the likelihood of delivering an effective vaccine that can be manufactured at scale.
The companies started a Phase 1/ 2 study in September, followed by a Phase 3 study by the end of 2020. If successful, and subject to regulatory considerations, the companies aim to have the vaccine available by the second half of 2021.
Together with the Member States and the European Medicines Agency, the Commission will use existing flexibilities to accelerate the authorisation and availability of successful vaccines against COVID-19. The regulatory processes will be flexible but remain robust. Any vaccine put on the market will have to meet the necessary safety requirements and undergo the scientific assessment by the European Medicines Agency as part of the EU market authorisation procedure.
Latest News from
Trade: EU reaches political agreement on updated enforcement regulation30/10/2020 13:25:00
The Council presidency has reached an agreement with the European Parliament on a revised enforcement regulation.
‘Everything is still to be agreed’: informal talks between Parliament and Council on Rule of law conditionality continue30/10/2020 12:38:00
Talks will continue in November, when the co-legislators will meet for the fifth trilogue on a mechanism to link EU funds to respect for rule of law.
Commission report: Europe's nature under threat as world suffers worst year on record for forest fires30/10/2020 12:08:00
Today, the Joint Research Centre of the Commission presented the 20th edition of its Annual Report on Forest Fires in Europe, the Middle East and North Africa, covering 2019.
2021 EU budget must focus on supporting a sustainable recovery from the pandemic30/10/2020 11:33:00
The main focus of the 2021 budget should be to mitigate the effects of the pandemic and support the recovery, building on the Green Deal and digital transformation.
InvestEU Fund: boost for sustainable, innovative and social investment30/10/2020 10:38:00
InvestEU aims to be a fund that provides support to EU investors by integrating and simplifying the financing, offered under a single budgetary guarantee scheme.
EU budget talks: Council rejects Parliament’s breakthrough proposal30/10/2020 09:25:00
EP’s negotiators made a breakthrough proposal on Wednesday on the critical issue of how to count the costs of common debt in the next long-term EU budget. Council has rejected it blindly.
Joint press release: EU-Canada Leaders' Virtual Meeting30/10/2020 08:20:00
The President of the European Council, Charles Michel, the President of the European Commission, Ursula von der Leyen, and the Prime Minister of Canada, Justin Trudeau, held a Leaders' Virtual Meeting on 29 October 2020.
EU strengthens trade enforcement arsenal with revamped regulation29/10/2020 16:33:00
The European Commission, the European Parliament and the Council yesterday reached a political agreement on reinforcing the EU's Enforcement Regulation.
Coronavirus resurgence: Commission steps up action to reinforce preparedness and response measures across the EU29/10/2020 15:25:00
The European Commission yesterday launched an additional set of actions to help limit the spread of the coronavirus, save lives and strengthen the internal market's resilience.
Combating child abuse online – Council ready to negotiate a temporary measure29/10/2020 14:33:00
Member states' ambassadors yesterday agreed on a negotiating mandate on temporary rules to allow providers of communications services such as web-based email and messaging services to continue detecting child sexual abuse online.